Larry Sanders
Psychiatry · Littleton, CONPI 1790813608
Payments from drug & device makers
Across 1,185 payments — averaging $657.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$712K
- Eli Lilly$19K
- Takeda Pharmaceuticals U.S.A., Inc.$17K
- Axsome Therapeutics, Inc.$11K
- Sunovion Pharmaceuticals Inc.$9K
- Boehringer Ingelheim$6K
- plus $5K from 17 others
What the payments were for
- Consulting fees$4,5651%
- Speaking & faculty fees$679,51489%
- Travel & lodging$57,2398%
- Food & beverage$18,1182%
- Education$1280%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 963 | $711,927 |
| Eli Lilly | 1 | $19,093 |
| Takeda Pharmaceuticals U.S.A., Inc. | 51 | $17,033 |
| Axsome Therapeutics, Inc. | 18 | $10,799 |
| Sunovion Pharmaceuticals Inc. | 28 | $9,122 |
| Boehringer Ingelheim | 6 | $5,570 |
| Eisai Inc. | 16 | $1,674 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $755 |
| Neurocrine Biosciences, Inc. | 8 | $672 |
| Alkermes, Inc. | 14 | $625 |
| Ironshore Pharmaceuticals Inc. | 5 | $211 |
| Lundbeck LLC | 11 | $207 |
| Corium, LLC | 7 | $195 |
| Idorsia Pharmaceuticals US Inc | 2 | $134 |
| Vanda Pharmaceuticals Inc. | 1 | $124 |
| Otsuka America Pharmaceutical, Inc. | 8 | $109 |
| Arbor Pharmaceuticals, Inc. | 5 | $90 |
| Adlon Therapeutics L.p. | 4 | $86 |
| Teva Pharmaceuticals USA, Inc. | 4 | $73 |
| Bausch Health US, LLC | 4 | $55 |
| Shire North American Group Inc | 3 | $48 |
| Tris Pharma Inc | 1 | $46 |
| Vertical Pharmaceuticals, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$778,656 in reported general payments places this provider in the 95th percentile of 559 psychiatry providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 12 | $109,910 |
| CaplytaLumateperone Tosylate | 13 | $21,976 |
| HorizantGabapentin Enacarbil | 11 | $13,484 |
| TrintellixVortioxetine Hydrobromide | 20 | $12,018 |
| FetzimaLevomilnacipran Hcl | 24 | $11,207 |
| LamictalLamotrigine | 26 | $9,143 |
| DayvigoLemborexant | 13 | $4,333 |
| Vilazodone Hcl | 11 | $2,431 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 29 | $2,129 |
| Quetiapine Fumarate | 39 | $1,260 |
| Methylphenidate Hcl | 17 | $1,221 |
| Clonazepam | 142 | $1,183 |
| Duloxetine Hcl | 41 | $999 |
| Lorazepam | 108 | $919 |
| Lamotrigine | 70 | $913 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $672 | $109,91012 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $755 | $21,97613 claims |
| Arbor Pharmaceuticals, Inc.Horizant | $90 | $13,48411 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $17,033 | $12,01820 claims |
| AbbVieFetzima | $711,927 | $11,20724 claims |
| Eisai Inc.Dayvigo | $1,674 | $4,33313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 559 psychiatry providers in Colorado.
Other psychiatry in Littleton
- Andrew SedilloAurora$3.7M
- David WeissHighlands Ranch$1.1M
- John HardyPueblo$887K
- Jeffrey RichmondDenver$424K
- Sara MarkeyDenver$209K
- Jennifer FrenchGlendale$115K
- Cynthia EppersonAurora$105K
- Yasas TanguturiAurora$95K
- Charles ParkLone Tree$89K
- Brian WiseCentennial$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.